logo
Share SHARE
FONT-SIZE Plus   Neg

Elan Raises $381 Mln In Sale Of 76% Of Alkermes Holding

Irish drugmaker Elan Corporation, plc (ELN) said Tuesday that it has raised about $381 million in net proceeds from the sale of 76%, or 24.15 million ordinary shares, of its shareholding in Alkermes plc (ALKS), net of underwriter fees.

Elan noted the proceeds further strengthen its cash balances and capital structure.

In September 2011, when Elan combined its Elan Drug Technology business with Alkermes Inc., Elan received $500 million in cash and 31.9 million ordinary shares in the newly created Alkermes plc.

After Tuesday's transaction, Elan continues to own 7.75 million Alkermes plc ordinary shares, which are subject to legal and contractual transfer restrictions.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Gold rallied Thursday morning as presumptive GOP nominee Donald Trump proclaimed himself a "low interest rate person" who would push for new leadership at the Federal Reserve. Trump said he would not reappoint current Fed Chair Janet Yellen, who happens to be one of the architects of the Fed's current... Merck & Co. Inc.(MRK) reported a profit for the first-quarter that grew 18 percent from the prior year, while quarterly sales declined 1 percent. Adjusted earnings per share topped analysts' expectations, while quarterly sales missed their estimates. Shares of WM Morrison Supermarkets Plc were gaining more than 4 percent in the early Thursday morning trading as it reported 0.7 percent increase in first-quarter like-for-like sales excluding fuel. LFL sales were up 1.2 percent, including fuel.
comments powered by Disqus
Follow RTT